SHANNON DUNLAP: Open Payments
NPI 1285231845 · OLANTA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$502 in 30 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $312 · 2025 $502
Food & beverage: $502
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 7 | $115 |
| Amgen Inc. | 6 | $98 |
| Novartis Pharmaceuticals Corporation | 5 | $79 |
| Novo Nordisk Inc | 4 | $69 |
| Insulet Corporation | 2 | $50 |
| Corcept Therapeutics | 3 | $46 |
| Stryker Corporation | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
Products named: FREESTYLE LIBRE 3, OTEZLA, LEQVIO, Ozempic, Omnipod, Korlym, Rybelsus, CT THROMBECTOMY SYSTEM KIT.
Industry payments across SC — which companies pay providers there.
